Cationic Amino Acid Transporter-2 Regulates Immunity by Modulating Arginase Activity
Robert W. Thompson(National Institutes of Health), Thomas A. Wynn(National Institute of Allergy and Infectious Diseases), Lesley G. Ellies, Stacy Ricklefs(National Institutes of Health), Stephen F. Porcella(National Institutes of Health), Lily Li, Allen W. Cheever(Biomedical Research Institute), Thirumalai R. Ramalingam(National Institutes of Health), John Pesce(National Institute of Allergy and Infectious Diseases), Sandy White(National Institutes of Health), Mark S. Wilson(Gene Therapy Laboratory)
Cited by 86
Related Papers
Type 2 immunity in tissue repair and fibrosis
|Nature reviews. Immunology|2017|1.1k
Pulmonary fibrosis: pathogenesis, etiology and regulation
|Mucosal Immunology|2009|834
Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis
|PLoS Pathogens|2009|808
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
|The Journal of Experimental Medicine|2010|740